Up a level |
Abooali, Maryam; Yasinska, Inna M; Schlichtner, Stephanie; Ruggiero, Sabrina; Berger, Steffen M; Cholewa, Dietmar; Milošević, Milan; Bartenstein, Andreas; Fasler-Kan, Elizaveta; Sumbayev, Vadim V (2024). Activation of immune evasion machinery is a part of the process of malignant transformation of human cells. Translational oncology, 39(101805), p. 101805. Elsevier 10.1016/j.tranon.2023.101805
Schlichtner, Stephanie; Yasinska, Inna M; Lall, Gurprit S; Berger, Steffen M; Ruggiero, Sabrina; Cholewa, Dietmar; Aliu, Nijas; Gibbs, Bernhard F; Fasler-Kan, Elizaveta; Sumbayev, Vadim V (2023). T lymphocytes induce human cancer cells derived from solid malignant tumors to secrete galectin-9 which facilitates immunosuppression in cooperation with other immune checkpoint proteins. Journal for immunotherapy of cancer, 11(1) BioMed Central 10.1136/jitc-2022-005714
Schlichtner, Stephanie; Yasinska, Inna M; Klenova, Elena; Abooali, Maryam; Lall, Gurprit S; Berger, Steffen M; Ruggiero, Sabrina; Cholewa, Dietmar; Milošević, Milan; Gibbs, Bernhard F; Fasler-Kan, Elizaveta; Sumbayev, Vadim V (2023). L-Kynurenine participates in cancer immune evasion by downregulating hypoxic signaling in T lymphocytes. Oncoimmunology, 12(1), p. 2244330. Taylor & Francis 10.1080/2162402X.2023.2244330
Mukaddam, Khaled; Ruggiero, Sabrina; Berger, Steffen M; Cholewa, Dietmar; Kühl, Sebastian; Vegh, Daniel; Payer, Michael; Bornstein, Michael M; Alhawasli, Farah; Fasler-Kan, Elizaveta (2022). Cytokines Activate JAK-STAT Signaling Pathway in MG-63 Cells on Titanium and Zirconia. Materials, 15(16) MDPI 10.3390/ma15165621
Schlichtner, Stephanie; Yasinska, Inna M; Ruggiero, Sabrina; Berger, Steffen M; Aliu, Nijas; Prunk, Mateja; Kos, Janko; Meyer, N Helge; Gibbs, Bernhard F; Fasler-Kan, Elizaveta; Sumbayev, Vadim V (2022). Expression of the Immune Checkpoint Protein VISTA Is Differentially Regulated by the TGF-β1 - Smad3 Signaling Pathway in Rapidly Proliferating Human Cells and T Lymphocytes. Frontiers in medicine, 9, p. 790995. Frontiers 10.3389/fmed.2022.790995